• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 SOLITAIRE FR4; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 SOLITAIRE FR4; CATHETER, THROMBUS RETRIEVER Back to Search Results
Model Number SFR4-4-40-10
Device Problem Break (1069)
Patient Problem Intracranial Hemorrhage (1891)
Event Date 06/04/2022
Event Type  Death  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received a report that the distal part of the solitaire pushwire separated.The proximal part was removed without any device, and the distal part was completely removed with a snare.It was reported that the patient experienced a subarachnoid hemorrhage and died. the devices were prepared according to the instructions for use (ifu).The patient was undergoing treatment for an ischemic stroke located in the middle cerebral artery.One pass was made with the device.Ancillary devices include a 6f cook sheath, phenom 21 microcatheter, and sofia 6f distal access catheter.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received indicating in the first control after removal of the torn material, there was no sign of bleeding.The bleeding was only seen in the control after the second passage with a new stent retriever.The pushwire was torqued during the procedure.There was moderate resistance encountered during the procedure.The patient's vessel tortuosity had usual elongation.The cause of the event was not determined.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Product analysis: as found condition: the solitaire x revascularization device was returned for analysis within a shipping box; within two sealed plastic biohazard pouches; within a dispenser coil and within an introducer sheath.The phenom-21 micro catheter involved in the event was not returned for analysis.Visual inspection/damage location details: the solitaire x pusher was found broken proximal to the marker coil with the ptfe jacket found damaged.The marker coil was found kinked.The solitaire x stent and attachment core wire were found separated from the pusher.No irregularities were found with the solitaire x proximal marker/attachment zone.No damages or irregularities were found with the solitaire x stent non-working (tear drop) length struts, the working length struts or the marker fingers.No other damages or irregularities were observed.Testing/analysis: n/a conclusion: based on the device analysis and reported information, the customer¿s report of ¿pushwire break/separation¿ was confirmed.Possible causes for failure are patient stenosis, vessel tortuosity, pre-existing stent, number of passes made with device, or new micro catheter was not used with each solitaire.Customer reported devices were prepared per ifu, one pass was made with device, pushwire was torqued during procedure, moderate resistance was encountered during procedure, and patient vessel tortuosity had ¿usual elongation¿.It is likely the reported resistance contributed towards the separation.The cause of the resistance could not be determined.As the phenom-21 micro catheter used in the event was not returned for analysis, any contribution of the micro catheter towards the resistance could not be assessed.The phenom-21 micro catheter has an inner diameter of 0.021¿, which is compatible for use with the solitaire x device.Customer reported that bleeding did not occur until after second pass with a new stent retriever.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLITAIRE FR4
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key14655400
MDR Text Key293725776
Report Number2029214-2022-00981
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K183022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 10/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSFR4-4-40-10
Device Catalogue NumberSFR4-4-40-10
Device Lot NumberB338431
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/15/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-